Skip to main content
BMJ - PMC COVID-19 Collection logoLink to BMJ - PMC COVID-19 Collection
. 2023 Apr 26;13(4):e068481. doi: 10.1136/bmjopen-2022-068481

Lived experience of patients with Long COVID: a qualitative study in the UK

Callum Thomas 1,2,, Mark A Faghy 1,2, Rebecca Owen 1,2, James Yates 1,2, Francesco Ferraro 1,2, Tom Bewick 3, Kate Haggan 3, Ruth E M Ashton 1,2
PMCID: PMC10151237  PMID: 37185640

Abstract

Background

Long COVID is a rapidly evolving global health crisis requiring interdisciplinary support strategies that incorporate the lived experience of patients. Currently, there is a paucity of research documenting the day-to-day experiences of patients living with Long COVID.

Objective

To explore the lived experience of Long COVID patients.

Study design

Longitudinal, observation study.

Setting

An inductive, data-driven, qualitative approach was used to evaluate hand-written diaries obtained from individuals who had been referred to a Derbyshire Long COVID clinic.

Participants

12 participants (11 females, age 49±10 years, 11 Caucasians) were recruited. Participants were included if they had a previous confirmed or suspected COVID-19 infection with ongoing recovery, >18 years old, understood the study requirements and provided informed consent.

Method

Participants were directed to complete self-report diaries over 16 weeks. Responses were transcribed verbatim and analysed using thematic analysis.

Results

Three key themes were highlighted: (1) understanding who helps patients manage symptoms, (2) daily activities and the impact on quality of life and health status and (3) the effect of turbulent and episodic symptom profiles on personal identity and recovery.

Conclusions

The novel challenges presented by Long COVID are complex with varying inter-related factors that are broadly impacting functional status and quality of life. Support mechanisms must incorporate the lived experiences and foster true collaborations between health professionals, patients and researchers to improve patient outcomes.

Trial registration number

NCT04649957.

Keywords: COVID-19, public health


STRENGTHS AND LIMITATIONS OF THIS STUDY.

  • Self-report diaries are flexible and adaptable methods that allow participants to record their feelings and lived experiences at their convenience.

  • The diaries allowed participants to open up and reveal nuanced details that, in the presence of a researcher, may not have been documented.

  • The diaries allowed participants to document their experiences over time rather than at predetermined moments where they may not have been prepared physically or emotionally to answer.

  • Participants were instructed to use the diaries freely and so entries were not made every day by some participants.

Introduction

Over the time course of the Coronavirus pandemic 2019 (COVID-19), international attention has predominantly focused on addressing the impact of acute infection. Thanks to effective and widespread vaccination this has undoubtedly reduced the severity of acute infections, observed by a reduction in hospitalisations and mortality.1 2 As such the focus has now shifted to restoring social and economic activities. Despite a shift in focus, we are still very much amid a pandemic that is demonstrating a lasting impact on public health.3 While vaccines reduce the likelihood of severe patient outcomes, it is established that vaccines do not prevent transmission or infection with SARS-CoV-2 and they offer minimal protection against postviral issues and symptom profiles, commonly referred to as Long COVID.

Defined by the WHO as ‘individuals with probable or confirmed COVID-19 diagnosis presenting symptoms 3 months after symptom onset, and symptoms lasting at least 2 months that cannot be explained by an alternative diagnosis’.4 Recent statistics estimate that >2 million people in the UK5 and 144.7 million globally6 are living with long-term and debilitating symptom profiles of Long COVID.7 The complex and episodic symptom profile is at the forefront of mechanistic investigations to increase pathological insight. Reports highlight the extent of physical, cognitive and psychosocial symptoms (ie, fatigue, brain fog and anxiety) and the impact on multiple bodily systems (ie, cardiovascular, respiratory and pulmonary system) that is becoming established8–10 Davis et al8 identified three symptom clusters that have distinct temporal profiles, cluster 1 identified early symptoms that peak and then diminish (ie, runny nose, loss of appetite, fever), cluster 2 represented stable symptoms (ie, nausea, chest tightness, fatigue), meanwhile cluster 3 represented symptoms that initially increase sharply then either plateau or slightly increase or decrease over the following months (ie, palpitations, brain fog, postexertional malaise).8 Another aspect reported via an online survey of Long COVID is the episodic nature of symptoms11 with 86% of participants (n=3252, 95% CI 84.8% to 87.0%) having symptoms triggered or exacerbated by physical or mental activities.8

Recent data suggest that 1 in 10 positive SARS-CoV-2 infections will go on to experience long-term illness.8 There is an unquestionable need to increase the pathological understanding to inform the design and development of bespoke and safe support services and pharmacological interventions for Long COVID patients. However, given the unique nature of COVID-19 and Long COVID, there is a need to engage the intended stakeholders and learn from the experiences of those living with this condition. Despite repeated calls from patients to incorporate the lived experience as a prominent feature in the design and implementation of research,12 there remains a lack of detail that provides thorough longitudinal insight from patients. Callan et al13 recognised the relapsing-remitting time course of Long COVID as an ‘episodic disability’ whereby participants reported brain fog that aligned with the unpredictable wellness and illness previously described in HIV-positive patients. However, the focus groups were followed up 4–6 months later by email and similarly provide a snapshot summary to that of online surveys. Witvliet14 retrospectively revealed the details of her personal Long COVID journey which included nuanced details that would not be captured in clinical pathways. This detail could provide important insight to support clinical decision-making but also in the development of Long COVID support pathways that are relevant, accepted and lead to improved patient outcomes. Patient diaries have previously been used in intensive care units and are useful tools to document patients’ lived experiences.15 16 Diaries are flexible and adaptable tools that can be used anytime and away from face-to-face research and clinical settings16 which can bridge the gap in communication between patients and healthcare providers.17 Diaries can allow Long COVID patients to remember their experiences independent of recall bias and without eliciting emotional difficulty that is brought about with an in-person consultation. However, the use of diaries in documenting the day-to-day lived experience of individuals with Long COVID is not commonplace and there is a paucity of data obtained that documents the longitudinal lived experience which is important in the design and development of specific support mechanisms.12 Accordingly, this study sought to capture the lived experience of individuals with Long COVID taking part in a 16-week observational study collected via hand-written diaries.

Methods

Following National Health Service (NHS) research ethics approval (IRAS ID: 292920) and informed consent, qualitative accounts of the lived experience of 12 Long COVID participants were recorded via diaries over 16 weeks. Previous postviral research and the paucity of SARS-CoV-2 infection recovery information influenced the study design rationale of 16 weeks; however, we acknowledge current recovery time extends beyond this significantly. The diaries formed part of a larger observational study powered by sample analysis techniques of individuals recovering at home from a SARS-CoV-2 infection. The sample presented here was a subsample of patients that completed the study. Data from the diaries were monitored continuously and analysed until saturation.18 At saturation, 17 participants had completed their involvement with 5 participants choosing not to fill out their diaries. Reasoning for non-completion included memory loss, energy prioritisation and depressive feelings towards diary use. Participants were recruited following a referral from an established Long COVID clinic where a participant information sheet and contact details were provided to obtain any further detail/clarifications. No time limit was placed on participation decision. Following the request to participate in the study, participants were passed onto the research team for consenting. As part of the study procedures listed entirely at ClinicalTrials.gov (NCT04649957), participants were provided with and directed to freely use a self-report diary, which was returned and photocopied monthly, to capture information that they deemed appropriate as part of their post-COVID-19 journey. This exploratory approach was appropriate given the lack of understanding of the lived Long COVID experiences, and a greater need to inform the development of bespoke support mechanisms.

Researcher characteristics

Researchers from the University of Derby had bimonthly contact with participants and instructed them to use diaries freely; this should have had limited impact on how they were used. All researchers had experience in their respective field of working with clinical populations with chronic conditions.

Patient and public involvement and engagement statement

Patient and public involvement and engagement was a crucial part of the research design, implementation of the project and interpretation of the resulting data reported in this manuscript. Previous research team experiences with pneumonia patients informed the data collection materials repurposed for this study. Participants were involved in raising awareness of our research to recruit participants in their Long COVID networks and will also be involved in the dissemination of the results by sharing the findings with their support groups and networks.

Data analysis

One researcher (CT, who a had previous experience with interview transcriptions) transcribed verbatim, coded and thematically analysed full diaries using the qualitative software NVivo V.12 Pro (V.12.7, QSR International, Doncaster, Australia). Alongside regular meetings, diary transcriptions were checked for accuracy by other members of the research team (MAF, REMA, RO, JY and FF). An inductive, data-driven approach was adopted to code the data into descriptive terms which were collated to produce 12 themes and 82 subthemes and grouped to generate three overarching themes. Two researchers (RO and JY, both with previous qualitative research experience) then reviewed 50% of the transcripts each with the generated themes and met with CT to confirm whether these were reflective of the presented data. These findings were then shared with the remainder of the research team (MAF, REMA and FF) and with two patient representatives for review; no adjustments were requested, and the themes were deemed reflective of the transcripts. Theme coverage was also generated by CT and denoted the percentage reporting of the theme across all the diaries.

Results

Participant characteristics are detailed in table 1 and are coincidentally skewed in representation towards white, middle-aged females, and are consistent with research in this area.19 Three key themes were identified: (1) understanding who helps patients manage symptoms, (2) daily activities and the impact on quality of life (QoL) and health status and (3) the effect of turbulent and episodic symptom profiles on personal identity and recovery.

Table 1.

Pooled participant pre-COVID-19, baseline and 16-week postbaseline measures (mean±SD)

Demographic profile Mean (±SD)
Age (years) 49±10
Sex Male (n=1)
Female (n=11)
Ethnicity White British (n=11)
Occupational status Employed full time (n=3)
Illness absence from work (n=8)
Retired (n=1)
Index of Multiple Deprivation decile 7±3
Performance status Pre-COVID-19 Baseline 16 weeks P values
Overall health (AU) 2±0.9 4±0.6 3±0.8 <0.001
COVID-19 symptom rating (AU) 8±1 7±2 0.324
PCFS (AU) 3±0.4 2±0.8 0.054
Dyspnoea (AU) 3±0.7 3±0.8 1.000
EQ5D-5L (AU) 13±3 13±5 0.575
EQ5D-5L VAS (AU) 46±16 47±22 0.691

Overall health score: 1–5 scale (1=very good and 5=very bad). COVID-19 symptom score: 0–10 rating of symptom effect on daily life (0=no impact/symptoms and 10=symptom/s have had a big effect). PCFS: 0–4 scale of functional status (0=no limitations and 4=severe limitations). Dyspnoea: 1–5 scale of breathlessness (1=breathless only with strenuous exercise and 5=too breathless to leave the house). EQ5D-5L, a self-assessed, health related, quality of life questionnaire, involves rating subcategories of mobility, self-care, usual activities, pain/discomfort and anxiety/depression on a 1–5 scale (1=no problems and 5=extreme problems or inability). EQ5D-5L VAS: 0–100 scale of perceived overall health (0=worst health they can imagine and 100 the best health they can imagine). Overall health data only for retrospective pre-COVID-19 evaluation.

P values are derived from paired samples t-tests.

AU, arbitrary unit; PCFS, Post-COVID-19 Functional Status; VAS, Visual Analogue Scale.

Theme 1: understanding who helps Long COVID patients with symptom management

Symptom management received 66% coverage with 2089/2911 references made to Long COVID symptoms. Furthermore, the broad and cyclical nature of symptoms highlights the day-to-day challenges associated with COVID-19 recovery:

… headache (lighter), aches/ pains in muscles/ joints, pains/ aches in chest, shortness of breath, brain pulsating, light ringing in ears. Thought I’d put the alarm on and I hadn’t, internal vibrations/pain in upper arms… kept losing focus in online training.

… went out for a meal with work for a couple of hours—felt good. Got home—symptoms returned intensely.

Pins and needles went yesterday evening. Arms feel wonderful again. No pins and needles in hand. Made such a difference to my mood today… Every day is a new day.

Available support options

Nine out of the 12 diaries made references relating to the awareness and availability of healthcare support to help participants cope with the challenges of living with Long COVID. There were regular suggestions that the services were unhelpful, underdeveloped and slow:

…neurology appointment came away disappointed and angry at lack of understanding…

Felt the doctor (as in GP) needs awareness raising more to Long COVID.

Chased Long COVID clinic been waiting since 25th June. Still, 2.5 months to wait at least!!

In response to frustration at a lack of services, participants reported opting to try self-treatment methods with mixed results. These include self-prescribed vitamin supplementation or changes to diet:

Can feel the benefits of B 12—less fatigue.

Still feel antihistamines and low histamine diet do help.

Other instances highlight that some experimental treatments resulted in symptom exacerbation:

…went to… oxygen centre for an intense therapy trial. Had to stop procedure after 15 minutes due to intensifying chest pain and blurred vision

Oxygen therapy. extremely tired, confusion + brain

Despite this frustration, there was recognition that care services to appropriately support their needs are developing:

Occupational therapist through LC clinic really supportive/ helpful.

Now seen CF [Chronic fatigue] clinic and improving pacing

Furthermore, a doctor within an established Long COVID clinic was able to identify symptoms associated with a pulmonary embolism and was able to make a referral for further examination.

Very good referrals to fatigue clinic, breathing clinic, vocational rehab, blood tests, eye checks. Go to A&E for blood clot check.

Family interdependence

The role of the family as part of the lived experience was also repeatedly noted. However, akin to healthcare support services, the data provided mixed findings. For example, some participants were very dependent on family and the support provided was crucial to everyday life and functional activity:

In a lot of pain after the walk, not comfortable going out without my wife support.

Totally exhausted and hardly able to do anything, my husband is looking after me.

The diaries also revealed that participants played an important role in supporting their families, usually in the form of some sort of task or responsibility. This commonly served to exacerbate symptoms such as brain fog which had negative outcomes:

Saw son + his girlfriend so cooked lunch for them—was fab to see them but wiped me out—everything ached and was shattered!!

Stayed at sons for night to look after his dogs, flooded kitchen, (forgot I'd left tap on).

Theme 2: daily activities and the impact on QoL

Symptoms were closely associated with QoL (29% coverage). This theme not only identified the impact on functional status and ability of participants to be physically active but also the numerous times they needed to recover and manage symptoms accordingly. Commonly reported symptoms of tiredness, fatigue and exhaustion were often managed with recovery periods:

…visit to see my Auntie. An exhausting day… genuine chest pain and tightness so sat down… my chest problems are worsening… exhausted so went upstairs straight away.

Went to a church service, walked but it was very slow, tiring and cause chest tightness. Went and lay on the bed all of the afternoon. Couldn't remember how long I slept.

Regardless of whether recovery was acute (ie, a quick nap on the sofa) or prolonged (ie, resting all day in bed), symptoms were not consistently alleviated, and it was commonplace for symptoms to persist and often become exacerbated:

Rested from 5pm—After a couple of hours symptoms intensified again. Had conversation with a friend and kept forgetting simple words.

Rested all afternoon. Made tea / struggled to walk my dog. All symptoms intensified, unable to do anything else, pains in muscles/joints particularly fingers/hands, forearms and elbows. Light headedness.

Changes in functional ability and physical activity

Persistent symptomology also impacted routine functional activities that pre-COVID-19 infection would have likely taken less time and energy to complete. This ranged from difficulty to concentrate during a task, as well as prolonging the length of time to complete that activity:

…writing Christmas cards out of my mind. Completed them but it took three hours. It took me three times longer than before I had Long COVID.

Took all day to Hoover and Polish

The ability to exercise had also changed, with a few accounts of low volume cycling, or light cross-trainer or treadmill activities reported. In most instances, targeted exercise for participants was intolerable:

The physios want me to continue the exercises at home but that is impossible for me to do.

Exercise but everything seems like one step forward and two steps [back]

There was a determination from participants to engage in physical activities. Walking was frequently reported however was consistently linked with an exacerbation of symptoms:

Try taking my dog for a walk… This was hard as my legs felt heavy and tired to move.

Walked 50 metres… very tiring and struggled with breathing on return journey.

Return to work was affected by Long COVID symptoms and some participants did not feel prepared to resume their careers due to the physical and mental challenges of work:

I am signed off work… still feel I would be unable to return to work at present (feel concerned whether I will ever be able to [return to] my job as a community nurse as it is a mentally and physically demanding role).

However, participants who returned to work described the experience as a ‘fight’, while having to manage the challenges of their symptoms alongside the financial pressures of having had an extensive period of leave from work:

Having to fight for every step as well as being ill.

Grief from work—half pay without notice.

Pacing as an activity management strategy

A key facet in all activities was the role of pacing. Participants were often keen to be functional and active, and pacing strategies helped them manage these activities:

Very tired this evening but know I would be so tea out the freezer. Getting better on these days. I’m not superhuman. I can pace.

Very tiring week… paced myself each day.

Specifically, advice from other people sharing their experiences helped participants pace and manage activities in their own lives:

Interesting interview on Lorraine with Nick Knowles TV presenter. after having COVID and wanting to get back into shape he returned to the gym and found exercised knocked him back with recovery. Quite interesting I think, since I've eased off with my morning gym sessions, I think it may be helping my recovery?

Another finding was that participants could pace their activities feeling ok until they stopped, thereafter symptoms were unbearable:

Helped install CCTV system, wanted to do something normal [to] see how I got on. Lots of breaks, pace myself, painkillers. Was OK until I stopped. Symptoms intensified immensely, nine out of 10

Therefore, it does seem that there is a limit of tolerance on the extent to which pacing can help during a particular activity, with education on the cumulative activity load across a time needing to be established:

Went to horse again and a walked at a steady pace with regular stops to get some fresh air. Left ear still blocked, whooshing and earache, left arm still weak and unable to lift for long without getting a cramping pain. Pain in feet and internal vibrations at night, still coughing phlegm up and a cough…

Postexertional symptom exacerbation

The symptom exacerbation following activities was widely reported; however, participants chose to still engage with certain activities despite knowing that symptoms would occur during or afterwards:

Went to a family wedding at 1:00pm. Very hard to make the effort but enjoyed seeing my nephew getting married. Had to leave early, was totally exhausted and went to bed at 7:00pm.

Went to meet a friend for coffee, exhausted after and needed to rest.

Socialising did not always reap the preconceived benefits and, on some occasions, served to make participants feel worse. This did not just exacerbate physical symptoms, but also presented mental and emotionally difficulties:

Taken to coffee but taking part in 1960s quiz very physically and mentally exhausted… failed miserably at quiz due to total brain fog… Went to bed again in the afternoon feeling very frustrated…

Theme 3: emotional impact of Long COVID symptoms on personal identity and recovery

Another theme that came from the analysis was the emotions and thoughts of our participants, and the impact of this on their personal identity and long-term recovery (5% coverage). A range of negative emotions accompanied changes in symptomology and functional capacity:

Came home and had a soak in the bath which took an hour to get over after getting out muscles and joints aching. By late afternoon muscles and joints nerve aching from head to toe… I was sobbing with the pain.

Had bad night sleep, feeling anxious + teary this morning. Feel unable to attend study appointment due to feeling unwell so have rescheduled.

Emotions were accompanied with comparisons to healthy individuals around them which frequently led to negative sentiments and feelings of despair:

Was taken to church in the morning followed by a fund-raising coffee morning for Macmillan Cancer Research. It made me aware of how I am still physically and mentally “disabled” due to how quickly other non-Long COVID people moved about.

Sitting on the side-lines watching everyone else live.

Furthermore, participants would also compare themselves to their preinfection state…:

Worried whether I will ever get back to pre Long COVID state.

Still ever present—the failing/knowledge that, without the sertraline, I would be in a little ball of depression. When will this end. Will I ever get my life back.

…with changes in identity and emotional sensitivity since infection also reported:

I was made aware that I now have very little compassion or empathy—I’m not the same person.

I just know I’m not me anymore.

Theme 4: episodic and undulating nature of Long COVID

An area that underpinned all themes was the undulating nature of the post-COVID-19 journey and the interconnectivity of all themes. Participants often revealed that it was commonplace to experience a period of improvement, followed by worsening of symptoms, day-by-day in some cases. However, this was often accompanied by comments regarding a correlated change in their QoL status and emotional state:

…sadly looks like another corner turned ☹. Energy levels even more. Craved carbs and chocolate.

Every day is a new day.

This was consistent across the 16-week period despite patients implementing management strategies, and it did not seem that patients became more expert at managing their condition.

However, the extended study period did reveal how seasonal weather changes may be somewhat, but not entirely, responsible for the episodic nature of the above themes:

Housebound [can't breathe cold air—Hurts] due to cold. Muscle and bones hurting a lot. Can’t regulate body temperature. In a lot of pain

Feeling a lot better with it getting warmer but my body is aching.

Discussion

To our knowledge, this is the first study to gather qualitative accounts over a longitudinal basis which highlights the day-to-day experiences of individuals living with Long COVID. The data highlight three key themes relating to: (1) understanding who helps patients manage symptoms, (2) daily activities and the impact on QoL, health status and the role of pacing in managing functional tasks and (3) the effect of turbulent and episodic symptom profiles on personal identity and recovery.

Evidently, the biggest challenge associated with Long COVID is a broad and debilitating symptom profile.10 Our work aligns with previous research that has identified the most prevalent symptom profiles associated with Long COVID.3 8 20 21 However, the diaries further outline the integration of symptoms with factors such as QoL status, and comparisons with healthy others and previous self, rather than considering these in isolation. For many participants, symptoms were managed by rest or sleep, and the diaries allowed participants to think more deeply about how this impacted their ability to undertake activities of daily life (ie, completing the school run or engaging in social activities). It was reported that when participants did attempt activities that are deemed low intensity this would exacerbate symptoms and lead to an extended period of convalescence. Accordingly, attempting to live with Long COVID requires considered support mechanisms that aim to help individuals understand changes in their physical, mental and emotional health which is in line with an episodic symptom profile that is prone to exacerbation. A further consideration is to understand the episodic nature of Long COVID. Participants here reported perceived improvements in symptom severity, often referring to ‘turning a corner’; however, this could change instantaneously and without any provocation in some cases, a finding that has been recognised in other studies.8 13 14 22 It has been suggested that patients with chronic diseases will increase activities when they feel able but with little consideration of the consequences.23 However, this does not align with our data which is better associated with the findings of Humphreys et al24 who report that Long COVID patients prioritise a sense of normality and control over relapse. Our findings indicate that pacing advice seems to have become more widespread and useful through Long COVID clinics and television programmes since this work. However, specific guidelines are still scarce and the diaries reveal detailed examples of how even sensible pacing strategies can result in ineffective outcomes. As such, further research is required to document changes in symptom profile relative to increased volume and intensity of activity to help better inform pacing advice.

Our data support that of Davis et al,8 who highlighted disparate recovery profiles that failed to reach a resolution 7 months postinfection, thus highlighting the individual nature and the need for tailored approaches.9 The broad and complex symptom profile of Long COVID makes it hard for health workers, family and friends to fully understand the realities of living with a debilitating and unpredictable condition.11 Our data reaffirm this understanding by demonstrating that multiple stakeholders are often involved in the Long COVID journey, which is representative of the multidimensional and complex presentation of this condition. Boix and Merino25 reported that many people with Long COVID have unfortunately struggled to have their condition recognised. Patients have, therefore, felt isolated and resulted to self-treatment methods given the lack of knowledge, understanding and bespoke treatments available for their condition and, in some instances, our data reaffirms the notion that this can deteriorate, rather than ameliorate, their health.26 27

Following critical illness, it can be commonplace to experience a range of difficult emotions and periods of stress which can manifest in the form of feeling tearful, lack of appetite and difficulty sleeping.28 Houben-Wilke et al29 demonstrate that negative emotions (ie, post-traumatic stress disorder, anxiety and depression) persist in some Long COVID patients 3 and 6 months after the onset of COVID-19 symptoms, with a prevalence comparable between hospitalised and non-hospitalised patients. Our data indicate in non-hospitalised participants that these emotions are frequently borne out of symptomology; however, the diaries were able to reveal real-time, daily examples of how comparisons to healthy individuals and preinfection states are centred at the heart of these thought processes. Houben-Wilke et al29 cited a lack of care and unmet needs as factors that contribute to negative emotions; however, future support services must incorporate methods to support grief due to loss of identity and purpose which is prominent among Long COVID patients. For example, meaning development, art therapies and journaling advanced by the four-phase model30 are proposed to be especially useful in grief management for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients who suffer from similar, but not identical, broad, long-term symptoms such as tiredness, sleep disturbances and brain fog. Further research is needed to deepen the understanding and integration between physical, mental and emotional support mechanisms.

Research surrounding the treatment and management of Long COVID is of international interest; however, there is limited evidence that repurposing existing clinical interventions has efficacy in addressing the unique and complex pathological mechanisms that underpin Long COVID. Therefore, bespoke, adaptive, flexible, interdisciplinary and patient-centred approaches are needed to support individuals with Long COVID.31–33 This is in keeping with one of our main findings which was the broad and undulating symptom profile reported by participants. Macpherson et al34 suggest services to support patients could take the form of ‘one-stop’ clinics in hospitals to treat patients holistically alongside established multidisciplinary departments. However, the diaries enabled participants to reflect on some of the biggest challenges associated with support services, which mainly included time to access support alongside GP understanding of Long COVID. As such, if ‘one-stop’ clinics cannot support demand nor validate patient concerns, then patients may refer to potentially harmful self-treatment methods that will exacerbate symptoms. Therefore, while ‘one-stop’ multidisciplinary approaches offer a potential solution, the complex clinical presentation with patient settings may be better suited to a detailed and expansive service that is underpinned by a comprehensive screening process that directs patients to the required services which act in a ‘buffet style system’ where patients can access (in both volume and intensity) services they require to positively influence clinical outcomes.

Multidisciplinary collaboration has been recommended as an approach for Long COVID support,3 35 and recent NHS policy36 has set out to drive multidisciplinary team working for those living with chronic health conditions which has been effective in significantly improving cancer care.37 However, given the nature of multidisciplinary teams (ie, lack of interaction and unison between members), it is postulated that this would have limited patient benefit.3 Alternatively, Tremblay et al38 found that patients with cancer under the care of teams working with a greater interdisciplinary intensity reported four times greater access to care compared with lower intensity teams; access which our participants reported as a major difficulty. Furthermore, Veronese et al39 found improvements in surgery waiting times through interdisciplinary teamwork even when factoring in socioeconomic barriers in upper-middle-income countries. Therefore, facilitating access through a ‘buffet-style’ approach in an interdisciplinary manner should ensure greater access to, and equity of, care.

Faghy et al3 suggest an interdisciplinary approach embedded in systems science may better help identify key stakeholders that can assist in the design, delivery and evaluation of support services. This will be vital given the prevalence of Long COVID6 combined with a chronically under-resourced and understaffed NHS.40 A group of stakeholders that could ease a growing clinical burden is clinical exercise specialists whose expertise can design and deliver holistic support programmes that recognises the individual and broad symptom profile. These professionals can develop and implement holistic support mechanisms that are tailored to the individual and whose expertise is not limited to the prescription of physical activity and exercise.31 33 Furthermore, working in an interdisciplinary manner with a broad spectrum of other rehabilitation experts inclusive of physical, lifestyle, behavioural and well-being practitioners would ensure other patient care needs are effectively supported. However, to be effective, it is important the lived experience is captured and incorporated into the entirety of the process to ensure the codesign and delivery of services address patient needs, are safe and are accepted by Long COVID patients.41 For example, it is widely acknowledged that key triggers (physical, cognitive and emotional) can prompt postexertional symptom exacerbation and/or relapse,8 which could explain why previous attempts to repurpose existing clinical interventions for Long COVID services have not been accepted and in some cases have been damaging (ie, the prescription of physical activity and graded exercise therapy).42–44 Early indications of the effectiveness of a personalised approach have been positive;45 however, these lack the involvement of the patient experiences in the design and testing process and so also risk rejection if not suitable in the applied setting. Gorna et al12 propose that an approach involving an individualised physical assessment by physicians with medical expertise to identify organ and multisystem dysfunction is also needed. If this approach was combined with further work inclusive of diary methodology, which this study has identified as useful in providing real-world, personalised postexertional symptom exacerbation experiences, then this could then inform individualised and wider rehabilitation/support plans that could also be inclusive of other key stakeholders (ie, employers when employees are returning to work). However, broad representation must be a key consideration in future work to ensure robust advice is provided, and the inclusion of the lived experience of minority groups with Long COVID also needs to be better understood.

A limitation of COVID-19 research, inclusive of our work, is the lack of ethnic diversity, male representation, young people, low socioeconomic groups and small sample sizes.8 22 34 46–48 Long COVID has a tendency to present more commonly in females than males;49 however, ethnic minorities have been disproportionately affected by the COVID-19 pandemic.50–52 A recent report by the National Institute for Health Research showed that the latter group constituted only 9% of cohorts in COVID-19 studies conducted in the UK. This is despite ethnic minorities constituting 14% of the general population in the UK.53 Current barriers to taking part in COVID-19 research have been postulated to include access to health services, language and mistrust.46–48 54 55 Gopal et al55 explain that existing equality and diversity recommendations to tackle these barriers (ie, cultural competency training) have the potential to do more harm than good through ethnocentrism and stereotyping. Instead, they recommend that a cultural safety approach engrained within a deep medicine ideology would be most appropriate. By focusing on the individual experience of care, staff self-reflexivity and structural reflexivity, Gopal et al55 postulate deep medicine would help overcome barriers such as mistrust and, subsequently, may help facilitate researcher–participant relationships in future research.56 57 Developing rapport by establishing and aligning with key principles valued by patients and reflecting with peers that challenge our own biases are just a couple of key examples of how future studies may look to develop trust and provide a safe, reassuring environment for ethnic minorities. This would be especially valuable in observational studies such as our own that require participant engagement over a prolonged period.

A merit of using diary methodology was how it enabled participants to reveal nuance experiences of their lives that, in the presence of a researcher, may not be easily recalled. For example, one participant reported crying as she did not have the energy to see her husband in hospital (online supplemental appendix A). The emotional cost of reliving a new way of living at a predetermined moment in-person may have been substantial where other energy requirements such as travel, conversation and sustained questioning may drain participant energy levels; unlike diary entries which could be completed at any time that was convenient to participants. However, quotes alike to this one lacked important detail which otherwise may have been explored with other research methodologies. For example, interviews would have been better suited to explore the source of self-treatment options.

Supplementary data

bmjopen-2022-068481supp001.pdf (53KB, pdf)

Conclusions

This study has added to a growing body of literature in sharing the lived experience of Long COVID from the perspective of the patients. Over 16 weeks, our work recognised the broad, disabling and episodic symptom profile of people living with Long COVID. It is vital more is done to support an already isolated group in a manner that not only provides validation to the Long COVID patient, but also a specific and adaptive support system that addresses the milieu of symptoms and undulating nature synonymous with Long COVID.

Supplementary Material

Reviewer comments
Author's manuscript

Acknowledgments

We would like to extend our sincere gratitude to our patients for their time, support, and development of our research on Long COVID.

Footnotes

Contributors: MAF and REMA conceived the idea of the study. All partners (CT, MAF, RO, JY, FF, TB, KH and REMA) were involved in recruitment and screening meanwhile CT, RO and JY led data collection. CT led data analysis and the writing of the manuscript, and all authors contributed to the development of the submitted manuscript and approved this before submission. MAF was responsible for the overall content and acted as the guarantor.

Funding: This study was supported by an unrestricted investigator-sponsored research grant from Gilead Sciences (#IN-UK-983-6080).

Competing interests: None declared.

Patient and public involvement: Patients and/or the public were involved in the design, or conduct, or reporting, or dissemination plans of this research. Refer to the Methods section for further details.

Provenance and peer review: Not commissioned; externally peer reviewed.

Supplemental material: This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.

Data availability statement

Data are available on reasonable request. Anonymised data can be made available on request.

Ethics statements

Patient consent for publication

Not applicable.

Ethics approval

This study involves human participants and ethical approval (IRAS ID: 292920) was granted by the Health Research Authority (HRA) and Health and Care Research Wales (HCRW). Participants gave informed consent to participate in the study before taking part.

References

  • 1.Collie S, Champion J, Moultrie H, et al. Effectiveness of BNT162b2 vaccine against omicron variant in South Africa. N Engl J Med 2022;386:494–6. 10.1056/NEJMc2119270 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.England P. New data show vaccines reduce severe COVID-19 in older adults. 2021. [Google Scholar]
  • 3.Faghy MA, Owen R, Thomas C, et al. Is long COVID the next global health crisis? J Glob Health 2022;12:03067. 10.7189/jogh.12.03067 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.WHO . A clinical case definition of post COVID-19 condition by a Delphi consensus. 2021. Available: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 [DOI] [PMC free article] [PubMed]
  • 5.ONS . Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK. 2022. Available: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/7july2022
  • 6.Wulf Hanson S, Abbafati C, Aerts JG, et al. A global systematic analysis of the occurrence, severity, and recovery pattern of long COVID in 2020 and 2021. MedRxiv 2022:2022.05.26.22275532. 10.1101/2022.05.26.22275532 [DOI] [Google Scholar]
  • 7.Perego E, Callard F, Stras L, et al. Why the patient-made term "long covid'' is needed. Wellcome Open Res 2020;5:224. 10.12688/wellcomeopenres.16307.1 [DOI] [Google Scholar]
  • 8.Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 2021;38:101019. 10.1016/j.eclinm.2021.101019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Faghy MA, Maden-Wilkinson T, Arena R, et al. COVID-19 patients require multi-disciplinary rehabilitation approaches to address persisting symptom profiles and restore pre-COVID quality of life. Expert Rev Respir Med 2022;16:595–600. 10.1080/17476348.2022.2063843 [DOI] [PubMed] [Google Scholar]
  • 10.Hayes LD, Ingram J, Sculthorpe NF. More than 100 persistent symptoms of SARS-CoV-2 (long covid): a scoping review. Front Med (Lausanne) 2021;8:750378. 10.3389/fmed.2021.750378 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Brown DA, O’Brien KK. Conceptualising long COVID as an episodic health condition. BMJ Glob Health 2021;6:e007004. 10.1136/bmjgh-2021-007004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Gorna R, MacDermott N, Rayner C, et al. Long covid guidelines need to reflect lived experience. Lancet 2021;397:455–7. 10.1016/S0140-6736(20)32705-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Callan C, Ladds E, Husain L, et al. "I C’ n't cope with multiple inputs'': a qualitative study of the lived experience of "brain FOG'' after COVID-19. BMJ Open 2022;12:e056366. 10.1136/bmjopen-2021-056366 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Witvliet MG. My 15-month rollercoaster ride with COVID-19: a social epidemiologist’s perspective. Scand J Public Health 2022;50:1–3. 10.1177/14034948211067682 [DOI] [PubMed] [Google Scholar]
  • 15.Roulin MJ, Hurst S, Spirig R. Diaries written for ICU patients. Qual Health Res 2007;17:893–901. 10.1177/1049732307303304 [DOI] [PubMed] [Google Scholar]
  • 16.Sansone V, Dall’Oglio I, Gesualdo F, et al. Narrative diaries in pediatrics: a scoping review. J Pediatr Nurs 2021;59:e93–105. 10.1016/j.pedn.2021.02.006 [DOI] [PubMed] [Google Scholar]
  • 17.Britton C, Moore A. Views from the inside, part 1: routes to diagnosis — families’ experience of living with a child with arthritis. British Journal of Occupational Therapy 2002;65:374–80. 10.1177/030802260206500805 [DOI] [Google Scholar]
  • 18.Fusch PI, Ness LR. Are we there yet? Data saturation in qualitative research. TQR 2015;20:1408–16. 10.46743/2160-3715/2015.2281 [DOI] [Google Scholar]
  • 19.Chaturvedi R, Lui B, Aaronson JA, et al. COVID-19 complications in males and females: recent developments. J Comp Eff Res 2022;11:689–98. 10.2217/cer-2022-0027 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Aiyegbusi OL, Hughes SE, Turner G, et al. Symptoms, complications and management of long COVID: a review. J R Soc Med 2021;114:428–42. 10.1177/01410768211032850 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: an overview. Diabetes Metab Syndr 2021;15:869–75. 10.1016/j.dsx.2021.04.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Ladds E, Rushforth A, Wieringa S, et al. Persistent symptoms after COVID-19: qualitative study of 114 "long cov’’'' patients and draft quality principles for services. BMC Health Serv Res 2020;20:1144. 10.1186/s12913-020-06001-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Burgoyne RW, Rourke SB, Behrens DM, et al. Long-term quality-of-life outcomes among adults living with HIV in the HAART era: the interplay of changes in clinical factors and symptom profile. AIDS Behav 2004;8:151–63. 10.1023/B:AIBE.0000030246.19577.fb [DOI] [PubMed] [Google Scholar]
  • 24.Humphreys H, Kilby L, Kudiersky N, et al. Long COVID and the role of physical activity: a qualitative study. BMJ Open 2021;11:e047632. 10.1136/bmjopen-2020-047632 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Boix V, Merino E. Post-COVID syndrome. The never ending challenge. Medicina Clínica (English Edition) 2022;158:178–80. 10.1016/j.medcle.2021.10.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Brown K, Yahyouche A, Haroon S, et al. Long covid and self-management. Lancet 2022;399:355. 10.1016/S0140-6736(21)02798-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Davies M. Long covid patients travel abroad for expensive and experimental "blood washing.'' BMJ 2022;378:1671. 10.1136/bmj.o1671 [DOI] [PubMed] [Google Scholar]
  • 28.NHS . Cognitive and emotional effects of recovering from COVID-19. n.d. Available: https://www.cuh.nhs.uk/our-services/neuropsychology/guide-cognitive-and-emotional-effects-recovering-covid-19/
  • 29.Houben-Wilke S, Goërtz YM, Delbressine JM, et al. The impact of long COVID-19 on mental health: observational 6-month follow-up study. JMIR Ment Health 2022;9:e33704. 10.2196/33704 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Fennell PA, Dorr N, George SS. Elements of suffering in myalgic Encephalomyelitis/Chronic fatigue syndrome: the experience of loss, grief, stigma, and trauma in the severely and very severely affected. Healthcare 2021;9:553. 10.3390/healthcare9050553 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Ashton R, Ansdell P, Hume E, et al. COVID-19 and the long-term cardio-respiratory and metabolic health complications. Rev Cardiovasc Med 2022;23:53. 10.31083/j.rcm2302053 [DOI] [PubMed] [Google Scholar]
  • 32.Faghy MA, Arena R, Stoner L, et al. The need for exercise sciences and an integrated response to COVID-19: a position statement from the International hl-pivot network. Prog Cardiovasc Dis 2021;67:2–10. 10.1016/j.pcad.2021.01.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Faghy MA, Ashton RE, Maden-Wilkinson TM, et al. Integrated sports and respiratory medicine in the aftermath of COVID-19. Lancet Respir Med 2020;8:852. 10.1016/S2213-2600(20)30307-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Macpherson K, Cooper K, Harbour J, et al. Experiences of living with long COVID and of accessing healthcare services: a qualitative systematic review. BMJ Open 2022;12:e050979. 10.1136/bmjopen-2021-050979 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Mishra V, Seyedzenouzi G, Almohtadi A, et al. Health inequalities during COVID-19 and their effects on morbidity and mortality. J Healthc Leadersh 2021;13:19–26. 10.2147/JHL.S270175 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.NHS . NHS people. 2020. Available: https://www.england.nhs.uk/ournhspeople/
  • 37.Taberna M, Gil Moncayo F, Jané-Salas E, et al. The multidisciplinary team (MDT) approach and quality of care. Front Oncol 2020;10:85. 10.3389/fonc.2020.00085 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Tremblay D, Roberge D, Touati N, et al. Effects of interdisciplinary teamwork on patient-reported experience of cancer care. BMC Health Serv Res 2017;17:218. 10.1186/s12913-017-2166-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Veronese ET, Pomerantzeff PMA, Jatene FB. Improving the heart team: an interdisciplinary team and integrated practice unit. World J Cardiol 2021;13:650–3. 10.4330/wjc.v13.i12.650 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Oliver D, Oliver D. David Oliver: the NHS’s understaffing is its Achilles’ heel. BMJ 2017;357:j2192. 10.1136/bmj.j2192 [DOI] [PubMed] [Google Scholar]
  • 41.Sivan M, Greenhalgh T, Darbyshire JL, et al. Long covid multidisciplinary Consortium optimising treatments and services across the NHS (locomotion): protocol for a mixed-methods study in the UK. BMJ Open 2022;12:e063505. 10.1136/bmjopen-2022-063505 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.D’Souza AF. Long COVID: implications for physiotherapy. European Journal of Physiotherapy 2021;23:384. 10.1080/21679169.2021.1937310 [DOI] [Google Scholar]
  • 43.Décary S, Gaboury I, Poirier S, et al. Humility and acceptance: working within our limits with long COVID and myalgic Encephalomyelitis/Chronic fatigue syndrome. J Orthop Sports Phys Ther 2021;51:197–200. 10.2519/jospt.2021.0106 [DOI] [PubMed] [Google Scholar]
  • 44.Vink M, Vink-Niese A. The updated nice guidance exposed the serious flaws in cbt and graded exercise therapy trials for me/cfs. Healthcare (Basel) 2022;10:898. 10.3390/healthcare10050898 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond) 2021;53:737–54. 10.1080/23744235.2021.1924397 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Chastain DB, Osae SP, Henao-Martínez AF, et al. Racial disproportionality in covid clinical trials. N Engl J Med 2020;383:e59. 10.1056/NEJMp2021971 [DOI] [PubMed] [Google Scholar]
  • 47.Etti M, Fofie H, Razai M, et al. Ethnic minority and migrant underrepresentation in COVID-19 research: causes and solutions. EClinicalMedicine 2021;36:100903. 10.1016/j.eclinm.2021.100903 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Sirotich E, Hausmann JS. Removing barriers and disparities in health: lessons from the COVID-19 pandemic. Nat Rev Rheumatol 2021;17:125–6. 10.1038/s41584-020-00524-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Sylvester SV, Rusu R, Chan B, et al. Sex differences in sequelae from COVID-19 infection and in long COVID syndrome: a review. Curr Med Res Opin 2022;38:1391–9. 10.1080/03007995.2022.2081454 [DOI] [PubMed] [Google Scholar]
  • 50.Jaljaa A, Caminada S, Tosti ME, et al. Risk of sars-cov-2 infection in migrants and ethnic minorities compared with the general population in the european who region during the first year of the pandemic: a systematic review. BMC Public Health 2022;22:143. 10.1186/s12889-021-12466-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Kirby T. Evidence mounts on the disproportionate effect of COVID-19 on ethnic minorities. Lancet Respir Med 2020;8:547–8. 10.1016/S2213-2600(20)30228-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Tai DBG, Sia IG, Doubeni CA, et al. Disproportionate impact of COVID-19 on racial and ethnic minority groups in the United States: a 2021 update. J Racial Ethn Health Disparities 2022;9:2334–9. 10.1007/s40615-021-01170-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.NIHR . NIHR research ethnicity data provides insight on participation in COVID-19 studies [Internet]. n.d. Available: https://www.nihr.ac.uk/news/nihr-research-ethnicity-data-provides-insight-on-participation-in-covid-19-studies/26460
  • 54.Enria L, Lees S, Smout E, et al. Power, Fairness and trust: understanding and engaging with vaccine trial participants and communities in the setting up the EBOVAC-salone vaccine trial in Sierra Leone. BMC Public Health 2016;16:1140. 10.1186/s12889-016-3799-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Gopal DP, Douglass C, Wong S, et al. Reflexivity, cultural safety, and improving the health of racially minoritised communities. Lancet 2022;399:1581–2. 10.1016/S0140-6736(22)00459-7 [DOI] [PubMed] [Google Scholar]
  • 56.Diallo BA, Usuf E, Ceesay O, et al. Clinical research on COVID-19: perceptions and barriers to participation in the Gambia. BMJ Glob Health 2022;7:e007533. 10.1136/bmjgh-2021-007533 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Schmotzer GL. Barriers and facilitators to participation of minorities in clinical trials. Ethn Dis 2012;22:226–30. [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary data

bmjopen-2022-068481supp001.pdf (53KB, pdf)

Reviewer comments
Author's manuscript

Data Availability Statement

Data are available on reasonable request. Anonymised data can be made available on request.


Articles from BMJ Open are provided here courtesy of BMJ Publishing Group

RESOURCES